Viral-vector gene therapies are here to stay. Keeping pace with increasing demand requires consideration of challenges, the potential for standardization, and strategizing for accelerating patient access.
Viral-vector therapies at scale: Today’s challenges and future opportunities
No comments:
Post a Comment